Boston Scientific Corp (BSX)
Cash ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 414,000 | 2,502,000 | 2,988,000 | 2,329,000 | 865,000 | 952,000 | 426,000 | 570,000 | 928,000 | 338,000 | 276,000 | 325,000 | 1,925,000 | 1,947,000 | 2,675,000 | 2,016,000 | 1,734,000 | 2,022,000 | 1,724,000 | 370,000 |
| Short-term investments | US$ in thousands | — | 117,000 | — | 1,730,000 | — | — | 4,000 | 4,000 | 4,000 | — | 4,000 | 7,000 | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 6,399,000 | 5,910,000 | 5,576,000 | 4,916,000 | 4,933,000 | 4,579,000 | 4,562,000 | 4,083,000 | 3,803,000 | 3,549,000 | 3,883,000 | 4,275,000 | 4,274,000 | 4,022,000 | 4,073,000 | 3,393,000 | 3,681,000 | 3,302,000 | 3,108,000 | 3,976,000 |
| Cash ratio | 0.06 | 0.44 | 0.54 | 0.83 | 0.18 | 0.21 | 0.09 | 0.14 | 0.25 | 0.10 | 0.07 | 0.08 | 0.45 | 0.48 | 0.66 | 0.59 | 0.47 | 0.61 | 0.55 | 0.09 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($414,000K
+ $—K)
÷ $6,399,000K
= 0.06
The cash ratio of Boston Scientific Corp has shown fluctuations over the analyzed period, ranging from as low as 0.06 to as high as 0.83. The cash ratio measures the company's ability to cover its short-term liabilities with its cash and cash equivalents. A higher cash ratio indicates a stronger ability to meet short-term obligations.
The ratio peaked at 0.83 on March 31, 2024, suggesting a significant increase in the company's cash reserves relative to its short-term liabilities at that point in time. This could be indicative of a period of strong cash generation or effective management of cash resources.
On the other hand, the lowest point of 0.06 was observed on December 31, 2024, indicating a lower level of cash reserves in relation to short-term liabilities. This could potentially signal a period of higher cash outflows or lower cash inflows impacting the company's liquidity position.
The fluctuations in the cash ratio demonstrate the importance of closely monitoring a company's cash position to ensure it has adequate liquidity to meet its financial obligations as they come due. Additionally, investors and stakeholders may use this ratio as a key indicator of the company's financial health and its ability to weather economic uncertainties.
Peer comparison
Dec 31, 2024